Suven Pharmaceuticals (SUVENPHAR.NSE) Q3 2024 Earnings

9AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
2
2.53
3.06
3.59

Details

Expected EPS
N/A
Actual EPS
2.41514376264
Surprise EPS
2.42
Surprise Percent
+∞%

Description

Suven Pharmaceuticals (SUVENPHAR.NSE) has reported earnings of 2.41514376264 per share for Q3 2024.

0 Comments

Share your thoughts